Patent · US Active

Method for determining presence of carcinomic cells with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine

US8975038B2 · kind B2 · utility

2Cited by
17References
1Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 16, 2013
Grant dateMar 10, 2015
Priority date
Expiry dateJul 16, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Presented is a method of determining the presence of carcinomic cells in a sample by contacting a sample of cells with a solution of TCPP to permit binding of the TCPP to components of the abnormal dysplastic or carcinomic cells, if any are present; detecting TCPP fluorescence in the sample, the presence of TCPP fluorescence being indicative that the sample contains dysplastic or carcinomic cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.